rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-9-14
|
pubmed:abstractText |
Re-intubation and re-operation may occasionally be required after neuromuscular block (NMB) reversal. This study evaluated block onset times of a second dose of rocuronium (1.2 mg kg(-1)) after sugammadex reversal of rocuronium 0.6 mg kg(-1).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1471-6771
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
105
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
487-92
|
pubmed:meshHeading |
pubmed-meshheading:20630888-Adolescent,
pubmed-meshheading:20630888-Adult,
pubmed-meshheading:20630888-Androstanols,
pubmed-meshheading:20630888-Drug Administration Schedule,
pubmed-meshheading:20630888-Female,
pubmed-meshheading:20630888-Humans,
pubmed-meshheading:20630888-Male,
pubmed-meshheading:20630888-Middle Aged,
pubmed-meshheading:20630888-Models, Biological,
pubmed-meshheading:20630888-Neuromuscular Blockade,
pubmed-meshheading:20630888-Neuromuscular Junction,
pubmed-meshheading:20630888-Neuromuscular Nondepolarizing Agents,
pubmed-meshheading:20630888-Pilot Projects,
pubmed-meshheading:20630888-Young Adult,
pubmed-meshheading:20630888-gamma-Cyclodextrins
|
pubmed:year |
2010
|
pubmed:articleTitle |
Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
|
pubmed:affiliation |
Department of Anaesthesiology and Critical Care Medicine, Onze-Lieve-Vrouw Ziekenhuis, Moorselbaan 164, 9300 Aalst, Belgium. guy.cammu@olvz-aalst.be
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|